American College of Cardiology

RWJBarnabas Health and Rutgers Health to Showcase Breakthrough Cardiology Data at the American College of Cardiology Scientific Session & Expo

Retrieved on: 
Lundi, mars 25, 2024
CMR, TME, FACC, National Health Interview Survey, Research, Obesity, Hypertension, MRI, Cooperman Barnabas Medical Center, Facial muscles, HIV, Diabetes, Risk, National Health, Patient, Stroke, RWJBarnabas Health, Community Medical Center, Mortality, Aortic stenosis, American College of Cardiology, Telehealth, Faculty, New Jersey Medical School, NHIS, Abstract, American College, Smoking, LVDD, Rutgers University, Division, TAVR, Collection, Jersey City Medical Center, ACC, YPLL, Acute coronary syndrome, Health, Meta-analysis, Dietary supplement

WEST ORANGE, N.J., March 25, 2024 /PRNewswire/ -- Physician-scientists from RWJBarnabas Health and Rutgers Health will present an extensive portfolio of innovative cardiovascular data from their clinical research program at the American College of Cardiology's (ACC) Annual Scientific Session & Expo in Atlanta, Georgia on April 6 to 8, 2024. A total of 59 abstracts have been accepted, composed of data evaluating and educating on risk factors, treatment options and ongoing research advances to improve cardiovascular care and outcomes for patients.

Key Points: 
  • A total of 59 abstracts have been accepted, composed of data evaluating and educating on risk factors, treatment options and ongoing research advances to improve cardiovascular care and outcomes for patients.
  • RWJBarnabas Health cardiac centers of excellence are nationally recognized for patient care and superior outcomes, including being named as one of Becker's top 100 Great Heart Programs in the country and recognized by American College of Cardiology as a Proven Quality Program.
  • Prior studies suggest that distinct patient subgroups with aortic stenosis may experience left ventricular systolic and diastolic dysfunction before the development of severe AS.
  • The study included patients who had received an angiogram done within 14 days of the CMR.

Aidoc and American College of Cardiology Collaborate to Revolutionize Cardiovascular Care with Best-in-Class AI

Retrieved on: 
Jeudi, février 29, 2024
Stroke, Algorithm, Radiology, AI, Health equity, MD, Physician, FDA, American College of Cardiology, Cardiovascular disease, Injury, GDMT, Calcium, Coronary artery disease, Splenic infarction, Risk, CAC, Documentation, Emergency department, American College, Organization, Patient, Anatomy, ACC

NEW YORK, Feb. 29, 2024 /PRNewswire/ -- AI pioneer Aidoc and the American College of Cardiology (ACC) are collaborating to revolutionize cardiovascular care through industry-leading artificial intelligence (AI) technology. This collaboration will drive enhanced outcomes for patients with incidentally identified coronary artery calcification (CAC) by ensuring that all patients receive the most effective follow-up and ACC guideline-concordant treatment.

Key Points: 
  • NEW YORK, Feb. 29, 2024 /PRNewswire/ -- AI pioneer Aidoc and the American College of Cardiology (ACC) are collaborating to revolutionize cardiovascular care through industry-leading artificial intelligence (AI) technology.
  • Aidoc's FDA-cleared proprietary technology communicates findings to radiologists and enables coordinated, automatic patient follow-up care.
  • "Our collaboration with Aidoc is aligned with the ACC's mission to transform cardiovascular care and improve heart health for all," stated Ami Bhatt, MD, Chief Innovation Officer, American College of Cardiology.
  • "Collaborating with the American College of Cardiology represents a landmark moment in our mission to harness AI's potential in healthcare.

Veradigm and American College of Cardiology Launch Influenza Vaccination Education Initiative to Improve Cardiovascular Health

Retrieved on: 
Mardi, février 13, 2024
Health Technology, White House, Federal Government, Data Management, Other Education, Technology, Practice Management, Pharmaceutical, Education, Professional Services, Infectious Diseases, Public Policy, Government, Cardiology, Biotechnology, Software, Data Analytics, Health, Senior, MD, Physician, American College of Cardiology, Cardiovascular disease, ACS, Practice management, EHR, Stroke, MBA, SCM, MDRX, Risk, HHS, Heart failure, Vaccination, Unitary state, CMSS, American College, Council, Acute coronary syndrome, Patient, Practice Fusion, CDC, ACC, Inc., VAX, Medical specialty, Evidence-based practice, Workflow, Pharmaceutical industry

Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions announced today the launch of TRANSFORM VAX, an American College of Cardiology (ACC)-sponsored initiative aimed at improving cardiovascular health through increased influenza vaccination education.

Key Points: 
  • Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions announced today the launch of TRANSFORM VAX, an American College of Cardiology (ACC)-sponsored initiative aimed at improving cardiovascular health through increased influenza vaccination education.
  • Influenza vaccination is associated with a lower risk for adverse cardiovascular events, with an overall 34% lower risk of major adverse cardiovascular events and a 45% lower risk among individuals with recent acute coronary syndrome (ACS).1 As part of this quality improvement initiative, Veradigm is delivering ACC-sponsored vaccination education messaging to a subset of cardiology practices using the Practice Fusion EHR (a Veradigm Network solution).
  • The messages appear as banner advertisements in an in-frame window adjacent to the EHR workflow that is separate and distinguishable from the clinical and practice management workflow within the EHR.
  • “Veradigm is proud to be working with the ACC to apply our real-world data in combination with our messaging capabilities to improve rates of recommended vaccinations for adults with cardiovascular disease,” said Stuart Green, Senior Vice President and General Manager at Veradigm.

Dr. Dennis Doan Champions Future Medical Leaders through Scholarship

Retrieved on: 
Jeudi, décembre 14, 2023
Medicine, American College of Cardiology, Research, Cardiology, Nasiriyah Heart Center, FACC, American College, Interventions, MBA, MD, Medical City, Society, Health, Moyamoya disease, Hospital, Management, Nursing

FORT WORTH, Texas, Dec. 14, 2023 /PRNewswire/ -- Dr. Dennis Doan , an esteemed figure in cardiology, launches the Dr. Dennis Doan Scholarship for Medical Students, a testament to his dedication to nurturing the next generation of medical professionals.

Key Points: 
  • FORT WORTH, Texas, Dec. 14, 2023 /PRNewswire/ -- Dr. Dennis Doan , an esteemed figure in cardiology, launches the Dr. Dennis Doan Scholarship for Medical Students, a testament to his dedication to nurturing the next generation of medical professionals.
  • With a career spanning over two decades, Dr. Dennis Doan , MD, MBA, FACC, RVPI, has consistently exemplified unwavering commitment to healthcare excellence.
  • His vision for healthcare education and his belief in nurturing the upcoming generation of medical talent led to the establishment of the Dr. Dennis Doan Scholarship for Medical Students.
  • For further information about the Dr. Dennis Doan Scholarship for Medical Students and to access the application, please visit https://drdennisdoanscholarship.com .

SHL Telemedicine Establishes US Nationwide Cardiology Network for ECG Interpretations and Telehealth Visits

Retrieved on: 
Lundi, novembre 6, 2023
Health, Medical Devices, Technology, Telemedicine, Virtual Medicine, Software, Cardiology, Hardware, Direct, American College, ECG, Telehealth, Automated ECG interpretation, Physician, Mortality, Cardiovascular disease, Quality of life, Hospital, CIE, SHL, D2C, Patient, American College of Cardiology, Medical imaging

A keystone of clinical cardiology, the electrocardiogram (ECG) remains the most widely performed test.

Key Points: 
  • A keystone of clinical cardiology, the electrocardiogram (ECG) remains the most widely performed test.
  • While computer-interpreted ECG programs (CIE) aid physicians in interpreting ECGs, they cannot replace the critical analysis provided by seasoned physicians.
  • In establishing a US Nationwide Cardiology Network, SHL has collaborated with HeartNexus, a team of nationally recognized, board-certified cardiologists specializing in cardiac test interpretation, peer-to-peer consultations, and on-demand patient telemedicine visits.
  • The ongoing developments embody SHL Telemedicine’s relentless pursuit of delivering unparalleled value to its customers and stakeholders while championing the transformative power of telemedicine.

iFR and FFR are equally safe to diagnose and treat heart disease according to largest-ever analysis of new real-world, long-term data

Retrieved on: 
Jeudi, octobre 26, 2023
Clinical Science (journal), Gold standard, European Society of Cardiology, AEX, Public sector banks in India, American College, Interventions, NYSE, INT, PHG, Pilot in command, ESC, Pressure, Lund University, Safety, Revascularization, American Heart Association, JACC, Risk, Guideline, MACE, PCI, Blood, FFR, TCT, Patient, Diagnosis, Death, EACTS, American College of Cardiology, Medical device, Pharmaceutical industry, Medical imaging, Cardiology

iFR is an innovative pressure-derived index only offered by Philips that is used to assess coronary blockages during interventional procedures.

Key Points: 
  • iFR is an innovative pressure-derived index only offered by Philips that is used to assess coronary blockages during interventional procedures.
  • The analysis, “Long-term Safety of Revascularization Deferral Based on Instantaneous Wave-Free Ratio or Fractional Reserve,” compares patient outcomes using iFR and FFR in the diagnosis and treatment of heart disease.
  • The cumulative MACE risks for each group differentiated by 1.6% (iFR: 21.5%, FFR: 19.9%, HR 1.09 (95% CI: 0.90-1.33 at 5 years).
  • iFR is considered the Gold Standard for hyperemia-free physiologic assessment for measuring pressure in diagnostic and interventional procedures [1,4].

Abridge raises $30M to Accelerate Adoption of its Proven Generative AI Solution across U.S. Healthcare Systems

Retrieved on: 
Jeudi, octobre 26, 2023
Technology, Health, Other Health, Artificial Intelligence, Payments, Other Technology, Practice Management, Software, General Health, Hospitals, Health Technology, Health Insurance, Data Management, Security, Documentation, Scan Group, Spark Capital, American College, University of Kansas Health System, Physician, Emory Healthcare, University of California, General partnership, Multimedia, Interface (computing), Trust, Caregiver, Partnership, University, Investment, Patient, Empathy, UPMC, Mayo Clinic, American College of Cardiology, Pharmaceutical industry, Medical device, Abridge

Abridge , the leader in generative AI for clinical documentation, announced a Series B raise of $30 million, led by Spark Capital.

Key Points: 
  • Abridge , the leader in generative AI for clinical documentation, announced a Series B raise of $30 million, led by Spark Capital.
  • This investment will support large-scale health system rollouts and accelerate product advances that will create additional value for patients, clinicians, and health systems.
  • View the full release here: https://www.businesswire.com/news/home/20231026850279/en/
    “Spark Capital is proud to lead this industry-defining investment in Abridge,” said Will Reed, a General Partner at Spark Capital focused on growth stage AI investments.
  • The solution has been uniquely designed with trust and auditability, providing the ability to quickly see source data from any AI-generated summary.

Avertix Data Presented at TCT 2023 Shows 150% Increase in Medication Adjustments of Antiarrhythmics for High-Risk Heart Attack Survivors

Retrieved on: 
Mardi, octobre 24, 2023
Patient, FDA, American College, Harvard Medical School, Splenic infarction, Beth Israel Deaconess Medical Center, History, Physician, Treatment, FACC, Cardiology, Acute coronary syndrome, Research, STEMI, Prescription, Risk, ACS, Coronary occlusion, FHRS, Safety, TCT, System, Vein, American College of Cardiology, Pharmaceutical industry, Medical device, Guardian, Electrophysiology

EATONTOWN, N.J., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Avertix Medical, Inc. (“Avertix” or the “Company”), creator of the world’s first and only real-time heart attack detection and patient alerting system designed to improve long-term management and outcomes of recurrent events in high-risk patients who have survived one or more heart attacks, announced The Guardian System™ data was presented today at the Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco. The study found an increase of more than 150% in new administration or titration of medications related to rate and rhythm abnormalities in patients whose Guardian™ alarms were activated compared to patients whose alarms were off.

Key Points: 
  • The Guardian System, the first and only FDA-approved implantable heart attack detection and warning system, also alerts patients in real-time of abnormal heart rates and rhythms and provides a recent history of intracardiac recordings.
  • “This data has provided us with valuable insights into addressing the care needs of high-risk Acute Coronary Syndrome (ACS) patients,” said Dr. Kaplan.
  • “With a career-long commitment to improving patient wellbeing and advancing cardiovascular research, The Guardian System is changing the paradigm for heart attack survivors,” said Dr. Gibson.
  • In addition to endpoints assessing ACS events, the trial collected data on medication usage and adjustments.

The Inner Circle Acknowledges, Abraham Bornstein as a Top Pinnacle Healthcare Professional for his contributions to the Cardiovascular and Physiology Fields

Retrieved on: 
Vendredi, octobre 13, 2023
Multimedia, Weill Cornell Medicine, Internal medicine, Physiology, Student, Public, Boston University, American College, Circulatory system, American College of Cardiology, Medicine, American Heart Association, American Board of Commissioners for Foreign Missions, Tufts University School of Medicine, Education, Maharishi International University, American Board of Internal Medicine, Inner circle, Nursing, Biology, Cardiology

NEW YORK, Oct. 13, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Abraham Bornstein is acknowledged as a Top Pinnacle Healthcare Professional for his contributions to the Cardiovascular and Physiology Fields.

Key Points: 
  • NEW YORK, Oct. 13, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Abraham Bornstein is acknowledged as a Top Pinnacle Healthcare Professional for his contributions to the Cardiovascular and Physiology Fields.
  • Dr. Bornstein pursued higher education at Boston University where he earned a Bachelor of Arts degree in Biology in 1969.
  • He then attended Tufts University School of Medicine in 1973 obtaining a Doctor of Medicine degree in 1973.
  • He has received many accolades during his career, including multiple teaching awards from Stanford Hospital and Practice.

Shimadzu Medical Systems USA installs first TRINIAS SCORE OPERA Cardiac Catheterization Lab in the US

Retrieved on: 
Vendredi, octobre 13, 2023
Certification, Hospital, Trinia, American College, American College of Cardiology, PCI, Joint Commission, MHA, Heart, Radiation, Percutaneous coronary intervention, Splenic infarction, Facial muscles, Platinum, Chest pain, MI, Shimadzu, Artery, NCDR, ICD, Stroke, Emergency, Vein, Cardiac catheterization, Blood, Patient, Quality of life, Medical imaging, South Carolina Lowcountry

LONG BEACH, Calif., Oct. 13, 2023 /PRNewswire/ -- Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, is proud to announce the first U.S. installation of a Trinias SCORE Opera C12 (ceiling-mounted cutting edge angiography system) at Beaufort Memorial Hospital (Beaufort, SC).

Key Points: 
  • LONG BEACH, Calif., Oct. 13, 2023 /PRNewswire/ -- Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, is proud to announce the first U.S. installation of a Trinias SCORE Opera C12 (ceiling-mounted cutting edge angiography system) at Beaufort Memorial Hospital (Beaufort, SC).
  • Shimadzu Medical Systems USA, is proud to announce the first U.S. installation of a Trinias SCORE Opera C12!
  • Beaufort Memorial Hospital marked the 20th anniversary of the Cochrane Heart Center with the opening of its newly renovated cardiac catheterization lab outfitted with the most advanced technology in the nation.
  • These patients require an urgent, minimally invasive stenting procedure called percutaneous coronary intervention (PCI) that is performed in the cath lab.